Moleculin Biotech, Inc. (MBRX)
MBRX Stock Price Chart
Explore Moleculin Biotech, Inc. interactive price chart. Choose custom timeframes to analyze MBRX price movements and trends.
MBRX Company Profile
Discover essential business fundamentals and corporate details for Moleculin Biotech, Inc. (MBRX) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
2 Jun 2016
Employees
17.00
Website
https://www.moleculin.comCEO
Walter V. Klemp
Description
Moleculin Biotech, Inc., a clinical-stage pharmaceutical company, focuses on the development of drug candidates for the treatment of highly resistant tumors and viruses. Its lead drug candidate is Annamycin that is in Phase 1/2 studies for the treatment of relapsed or refractory acute myeloid leukemia (AML) and cancers metastasized to the lungs. The company's flagship immune/transcription modulator is WP1066, which is in Phase I clinical trial for the treatment of brain tumors and pediatric brain tumors, as well as pancreatic cancer and other malignancies. It also develops WP1220, an analog of WP1066 for the topical treatment of cutaneous T-cell lymphoma; and WP1122 to treat glioblastoma multiforme and COVID-19. The company has partnership and collaboration agreements with MD Anderson; Animal Life Sciences, LLC; and WPD Pharmaceuticals Sp z.o.o. Moleculin Biotech, Inc. was incorporated in 2015 and is headquartered in Houston, Texas.
MBRX Financial Timeline
Browse a chronological timeline of Moleculin Biotech, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 11 May 2026
Upcoming earnings on 14 Nov 2025
EPS estimate is -$0.20.
Earnings released on 12 Aug 2025
EPS came in at -$0.49 falling short of the estimated -$0.39 by -25.64%.
Earnings released on 13 May 2025
EPS came in at -$0.69 surpassing the estimated -$0.71 by +2.82%.
Earnings released on 21 Mar 2025
EPS came in at -$0.37 surpassing the estimated -$1.54 by +75.97%.
Earnings released on 11 Nov 2024
EPS came in at -$2.85 falling short of the estimated -$2.44 by -16.80%.
Earnings released on 13 Aug 2024
EPS came in at -$2.23 falling short of the estimated -$2.10 by -6.19%.
Earnings released on 10 May 2024
EPS came in at -$2.02 surpassing the estimated -$3.59 by +43.73%.
Earnings released on 22 Mar 2024
EPS came in at -$5.02 falling short of the estimated -$3.05 by -64.59%, while revenue for the quarter reached $406.00K .
Stock split effective on 22 Mar 2024
Shares were split 1 : 15 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 13 Nov 2023
EPS came in at -$2.85 surpassing the estimated -$3.15 by +9.52%.
Earnings released on 11 Aug 2023
EPS came in at -$3.00 surpassing the estimated -$4.20 by +28.57%.
Earnings released on 11 May 2023
EPS came in at -$4.20 falling short of the estimated -$3.75 by -12.00%.
Earnings released on 22 Mar 2023
EPS came in at -$3.60 surpassing the estimated -$4.20 by +14.29%.
Earnings released on 10 Nov 2022
EPS came in at -$4.50 falling short of the estimated -$4.05 by -11.11%.
Earnings released on 15 Aug 2022
EPS came in at -$3.60 surpassing the estimated -$3.75 by +4.00%.
Earnings released on 11 May 2022
EPS came in at -$3.60 falling short of the estimated -$3.15 by -14.29%.
Earnings released on 25 Mar 2022
EPS came in at -$2.55 surpassing the estimated -$3.15 by +19.05%.
Earnings released on 11 Nov 2021
EPS came in at -$2.25 surpassing the estimated -$3.00 by +25.00%.
Earnings released on 12 Aug 2021
EPS came in at -$2.85 surpassing the estimated -$3.00 by +5.00%.
Earnings released on 12 May 2021
EPS came in at -$3.00 surpassing the estimated -$3.90 by +23.08%.
Earnings released on 24 Mar 2021
EPS came in at -$0.26 surpassing the estimated -$0.58 by +55.17%.
Stock split effective on 1 Feb 2021
Shares were split 1 : 6 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 13 Nov 2020
EPS came in at -$5.40 surpassing the estimated -$8.99 by +39.93%.
MBRX Stock Performance
Access detailed MBRX performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.